[HTML][HTML] Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon, BS Cha - World journal of hepatology, 2014 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …
[PDF][PDF] Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon, BS Cha - World, 2014 - pdfs.semanticscholar.org
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …
[引用][C] Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon - World Journal of Hepatology, 2014 - cir.nii.ac.jp
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF][PDF] Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon, BS Cha - World, 2014 - core.ac.uk
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
HJ Yoon, BS Cha - World journal of hepatology, 2014 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon, BS Cha - 2014 - ir.ymlib.yonsei.ac.kr
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …
[HTML][HTML] Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon, BS Cha - World Journal of Hepatology, 2014 - wjgnet.com
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease.
HJ Yoon, BS Cha - World Journal of Hepatology, 2014 - europepmc.org
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
H Yoon, BS Cha - World Journal of Hepatology, 2014 - wjgnet.com
Figure 1 Mechanism of hepatic insulin resistance and the key pathway of drug action.
Delivery of FFAs to the liver and skeletal muscle is increased in insulin resistance …
Delivery of FFAs to the liver and skeletal muscle is increased in insulin resistance …
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease.
HJ Yoon, BS Cha - World Journal of Hepatology, 2014 - europepmc.org
Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …
and its incidence continues to increase with the increasing prevalence of other metabolic …